GenapSys

Meridian CEO Jack Kenny said the firm needs to develop a new MDx platform, while Genapsys resurfaced with an update on its portable sequencing platform.

Sigma-Aldrich has been developing reagents for the Genius platform for about a year.

This article was originally published February 17.

NEW YORK (GenomeWeb News) –GenapSys said today that it has raised $37 million in a Series B financing round to support commercialization of its next-generation sequencing platform.

NEW YORK (GenomeWeb News) – DNA sequencing technologies startup GenapSys has raised $8.5 million of a target goal of $13.6 million, the company disclosed in a document recently filed with the US Securities and Exchange Commission.

Informatics startup Syapse said this week that it has raised $3 million in Series A venture capital funding to support continued development of software for use in next-generation sequencing-based diagnostics.

People In The News

NEW YORK (GenomeWeb News) – Agilent Technologies said this week that it has appointed Ron Nersesian to be company president as well as chief operating officer, effective immediately.

This article has been updated with additional information from GenapSys.

Genapsys has expanded its management team and scientific advisory board.

NEW YORK (GenomeWeb News) – The National Human Genome Research Institute said today that it has pumped $19 million into new research and development projects that seek to bring down the costs of DNA sequencing.

Pages

An artificial intelligence-based analysis suggests a third group of ancient hominins likely interbred with human ancestors, according to Popular Mechanics.

In Science this week: reduction in bee phylogenetic diversity, and more.

The New York Times Magazine looks into paleogenomics and how it is revising what's know about human history, but also possibly ignoring lessons learned by archaeologists.

The Economist reports on Synthorx's efforts to use expanded DNA bases they generated to develop a new cancer drug.